✦ LIBER ✦

Prognostic Significance of FDG-PET in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Standard Salvage Chemotherapy and Autologous Stem Cell Transplantation

✍ Scribed by Jacob P. Smeltzer; Amanda F. Cashen; Qin Zhang; Andrew Homb; Farrokh Dehdashti; Camille N. Abboud; John F. DiPersio; Keith E. Stockerl-Goldstein; Geoffrey L. Uy; Ravi Vij; Peter Westervelt; Nancy L. Bartlett; Todd A. Fehniger

Book ID: 116282666
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 257 KB
Volume: 17
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2011.04.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose chemotherapy and autologous st

High-dose chemotherapy and autologous stem cell transplant in adolescent patients with relapsed or refractory Hodgkin's lymphoma

✍ El Weshi, A; Rahal, M; Abdelsalam, M; Al Husseini, H; Maghfoor, I; Akhtar, S 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 200 KB

Ifosfamide, Idarubicin, and Etoposide in

Ifosfamide, Idarubicin, and Etoposide in Relapsed/Refractory Hodgkin Disease or Non-Hodgkin Lymphoma: A Salvage Regimen with High Response Rates before Autologous Stem Cell Transplantation

✍ Basak Oyan; Yener Koc; Evren Ozdemir; Ayse Kars; Alev Turker; Gulten Tekuzman; E 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Pre-transplant positron emission tomogra

Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin’s lymphoma

✍ Cremerius, U; Fabry, U; Wildberger, J E; Zimny, M; Reinartz, P; Nowak, B; Schaef 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 178 KB

Pre-transplant positron emission tomogra

✍ Cremerius et al, 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 28 KB

Phase II study of autologous transplanta

Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma

✍ Koen Van Besien; Rakesh Mehra; Navin Wadehra; Wendy Stock; Issa Khouri; Sergio G 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Gemcitabine, Busulfan and Melphalan (Gem

Gemcitabine, Busulfan and Melphalan (Gem/Bu/Mel) Is a New High-Dose Chemotherapy (HDC) Regimen with High Activity in Refractory or Poor-Risk Relapsed Non-Hodgkin'S Lymphoma (NHL) Patients Receiving an Autologous Stem-Cell Transplant (ASCT)

✍ Y. Nieto; R.B. Jones; U. Popat; B. Andersson; B. Valdez; P. Thall; E.J. Shpall; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB